MedTrace Logo

To Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Multiple Doses AZD8848 in Healthy Subjects

NCT01818869 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 8

Last updated 2015-08-14

No results posted yet for this study

Summary

This study will investigate the safety, tolerability, pharmacokinetics and pharmacodynamics of multiple ascending doses of AZD8848 in healthy subjects.

Conditions

  • Safety,
  • Tolerability,
  • Healthy Subjects

Interventions

DRUG

AZD8848

Multiple doses inhaled IMP via a nebulizer

DRUG

Placebo to match AZD8848

Multiple doses inhaled matching placebo via a nebulizer

Sponsors & Collaborators

Principal Investigators

  • Tim Mant, BSc, MB BS, MRCP, FRCP, FFPM · Quintiles Drug Research Unit at Guy's Hospital, 6 Newcomen Street London SE1 1YR UK

  • Aray Aggarwal · AstraZeneca Pharmaceuticals 35 Gathouse Drive, Waltham, Ma 02451 United States

Study Design

Allocation
RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
50 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2014-01-31
Primary Completion
2014-02-28
Completion
2014-02-28

Countries

  • United Kingdom

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01818869 on ClinicalTrials.gov